Flexural Exanthema From Enfortumab Vedotin

Urothelial malignancies are commonly treated with platinum-based therapies. Newer trials have tested antimitotic therapies such as enfortumab vedotin as viable treatment therapy for refractory malignany. Enfortumab vedotin targets nectin-4, a member of a family of calcium-dependent, immunoglobulin-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Keerty, Dinesh, Graham, Laura, Haynes, Elizabeth, Hembree, Timothy N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Dermatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292715/
https://www.ncbi.nlm.nih.gov/pubmed/32542157
http://dx.doi.org/10.7759/cureus.8102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292715/
https://www.ncbi.nlm.nih.gov/pubmed/32542157
http://dx.doi.org/10.7759/cureus.8102

Ejemplares similares